Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive physostigmine salicylate in perioperative sepsis/septic shock
2012-001650-26Phase 3Completed
- Sponsor
- Heidelberg University
- Start
- Aug 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis and septic shock comparing Anticholium arm with Placebo arm (2 arms). Primary endpoint: Mean SOFA score. Started Aug 2012; status: completed.
02
Drugs
physostigmine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on 2012-001650-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001650-26.